Scholars Central

ArticlePublished 18 Jan 2024

Meta-Analysis of Long-Term Effectiveness of Bortezomib in Managing Multiple Myeloma

Authors: Ying Liu, Peng Cheng, Lihua Zhu, H. Dong

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

A meta-analysis was conducted to figure out the long-term effectiveness of bortezomib in managing patients with multiple myeloma. To retrieve relevant literature, the Chinese National Knowledge Infrastructure and Wanfang databases were searched using the keywords bortezomib, multiple myeloma, and long-term efficacy. Additionally, Embase, the Web of Science, PubMed, and Cochrane Library databases were queried using the terms bortezomib, multiple myeloma, and long-term effect. Two assessors utilized Cochrane scoring to evaluate the quality of the articles. Retrieve pertinent data from the included research articles and analyze it using RevMan 5.4 software to evaluate the effectiveness of bortezomib through meta-analysis. Ten publications were incorporated into the meta-analysis. According to the findings of the meta-analysis, patients undergoing consolidation therapy for multiple myeloma exhibited significantly superior progression-free survival and overall survival outcomes when treated with bortezomib compared to those who were not. In terms of overall survival during consolidation therapy, there was no notable distinction observed between the two groups of patients. Additionally, the funnel plot analysis indicated the absence of any significant publication bias. This meta-analysis unequivocally establishes the notable advantages of utilizing bortezomib as an initial medication choice for consolidation and maintenance therapy in multiple myeloma. Significant enhancements in both progression-free survival and overall survival were observed, underscoring its efficacy.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Indian Journal of Pharmaceutical Sciences.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalIndian Journal of Pharmaceutical Sciences
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Ying Liu”
  • BylineArticles whose byline prints “Peng Cheng”
  • BylineArticles whose byline prints “Lihua Zhu”
  • BylineArticles whose byline prints “H. Dong”